-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Adp-53DCV in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adp-53DCV in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adp-53DCV in Breast Cancer Drug Details: Adp-53DCV (MX-225) is under development for...
-
Product Insights
ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 – Drugs In Development, 2023
Global Markets Direct’s ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 provides in depth analysis on ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Poly [ADP Ribose] Polymerase 2 – Drugs In Development, 2023
Global Markets Direct’s Poly [ADP Ribose] Polymerase 2 provides in depth analysis on Poly [ADP Ribose] Polymerase 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Poly...
-
Product Insights
Poly [ADP Ribose] Polymerase 1 – Drugs In Development, 2023
Global Markets Direct’s Poly [ADP Ribose] Polymerase 1 provides in depth analysis on Poly [ADP Ribose] Polymerase 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Poly...
-
Product Insights
Protein Mono ADP Ribosyltransferase TIPARP – Drugs In Development, 2023
Global Markets Direct’s Protein Mono ADP Ribosyltransferase TIPARP provides in depth analysis on Protein Mono ADP Ribosyltransferase TIPARP targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Protein...
-
Product Insights
Poly [ADP Ribose] Polymerase 3 – Drugs In Development, 2023
Global Markets Direct’s Poly [ADP Ribose] Polymerase 3 provides in depth analysis on Poly [ADP Ribose] Polymerase 3 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Poly...
-
Company Insights
Innovation and Patenting activity of Groupe ADP Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Groupe ADP Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RP-12146 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-12146 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RP-12146 in Breast Cancer Drug Details: RP-12146 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ADP-101 in Food Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ADP-101 in Food Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ADP-101 in Food Allergy Drug Details:ADP-101 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vicagrel in Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vicagrel in Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vicagrel in Ischemic Stroke Drug Details: Vicagrel was under investigation for the...